Published in Br J Cancer on January 01, 1997
Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet (1982) 2.02
Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. Chest (1995) 1.92
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers. Am J Clin Pathol (1994) 1.52
Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer (1985) 1.25
Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer. J Natl Cancer Inst (1986) 1.02
Neuron-specific enolase. Int J Biol Markers (1995) 1.01
Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer (1990) 1.00
Serum tumour markers in lung cancer: history, biology and clinical applications. Eur Respir J (1994) 0.95
Discriminant analysis on small cell lung cancer and non-small cell lung cancer by means of NSE and CYFRA-21.1. Eur Respir J (1995) 0.92
Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer. Semin Oncol (1992) 0.84
Value of serum neuron-specific enolase in nonsmall cell lung cancer. Oncology (1993) 0.83
Detection of Helicobacter pylori carriers by discriminant analysis of urea and pH levels in gastric juices. J Clin Pathol (1991) 0.81
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect (2014) 2.13
Gastrointestinal symptoms in patients with asthma. Arch Dis Child (2000) 1.82
miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ (2011) 1.77
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers. Am J Clin Pathol (1994) 1.52
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin. J Clin Microbiol (1995) 1.48
Improving feasibility of posterior descending coronary artery flow recording by transthoracic Doppler echocardiography. Eur J Echocardiogr (2003) 1.45
Immunohistologic analysis of mycobacterial antigens by monoclonal antibodies in tuberculosis and mycobacteriosis. Hum Pathol (1989) 1.41
Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther (2003) 1.40
Are serum interleukin-6 levels always useful for differentiating monoclonal gammopathies in unselected patients? Blood (1992) 1.39
Small cell lung cancer. Ann Oncol (2006) 1.30
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project. J Clin Oncol (1999) 1.27
A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J Infect Dis (1994) 1.27
Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol (2001) 1.27
Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis. Am J Respir Crit Care Med (1998) 1.22
Influence of blunt needles on surgical glove perforation and safety for the surgeon. Am J Surg (1996) 1.21
Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J Biol Regul Homeost Agents (1998) 1.21
Cosmid vectors for high efficiency DNA-mediated transformation and gene amplification in mammalian cells: studies with the human growth hormone gene. Gene (1986) 1.16
Genome search in celiac disease. Am J Hum Genet (1998) 1.14
Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients--relationships with disease severity. Clin Exp Dermatol (1994) 1.12
Cytokines in psoriasis. Int J Dermatol (1999) 1.12
Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Br J Dermatol (2007) 1.12
Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. AIDS Res Hum Retroviruses (1992) 1.11
Differences in the expression and release of DR, BR, and DQ molecules in human cells treated with recombinant interferon gamma: comparison to other interferons. Hum Immunol (1985) 1.09
Cancer incidence and mortality among flight personnel: a meta-analysis. Aviat Space Environ Med (2000) 1.09
Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J Virol (1995) 1.07
Acute hepatitis complicating Mycoplasma pneumoniae infection. J Infect (1988) 1.07
Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther (2003) 1.06
Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect Immun (1983) 1.06
Cost-effectiveness of universal MRSA screening on admission to surgery. Clin Microbiol Infect (2010) 1.06
Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. Am J Respir Crit Care Med (1999) 1.06
Cosmic radiation and cancer mortality among airline pilots: results from a European cohort study (ESCAPE). Radiat Environ Biophys (2003) 1.05
Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J Endocrinol (2002) 1.03
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection. AIDS Res Hum Retroviruses (1999) 1.01
Allogeneic cellular gene therapy in hemoglobinopathies--evaluation of hematopoietic SCT in sickle cell anemia. Bone Marrow Transplant (2011) 1.01
HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res Hum Retroviruses (1995) 1.01
Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate. Bone (1988) 1.00
Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis. Eur Cytokine Netw (2000) 0.98
Detection of JC and BK viral genome in specimens of HIV-1 infected subjects. New Microbiol (1997) 0.98
A new assay for choline-containing phospholipids in amniotic fluid by an enzyme sensor. Clin Chim Acta (1987) 0.97
Linear and non-linear 24 h heart rate variability in chronic heart failure. Auton Neurosci (2000) 0.97
Prevalence of pilus-encoding islets among acute otitis media Streptococcus pneumoniae isolates from Israel. Clin Microbiol Infect (2010) 0.96
Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. Eur Cytokine Netw (1997) 0.96
Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease. Gut (2007) 0.95
Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. AIDS Res Hum Retroviruses (1993) 0.95
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability. J Infect Dis (2000) 0.94
Abdominal tuberculosis mimicking Crohn's disease: a difficult diagnosis. Report of a case. Panminerva Med (2002) 0.94
Limitations of qualitative serum beta-HCG assays in the diagnosis of ectopic pregnancy. J Reprod Med (1983) 0.93
Sarcoidosis in Europe: a cooperative study. Ann N Y Acad Sci (1976) 0.93
Diagnostic relevance of polymerase chain reaction technology for T. pallidum in subjects with syphilis in different phases of infection. New Microbiol (1999) 0.92
Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats. Br J Pharmacol (2007) 0.92
Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft. Bone Marrow Transplant (2008) 0.92
Transient small-bowel intussusceptions in adults: significance of ultrasonographic detection. Clin Radiol (2007) 0.92
Discriminant analysis on small cell lung cancer and non-small cell lung cancer by means of NSE and CYFRA-21.1. Eur Respir J (1995) 0.92
alpha1-adrenergic receptor subtypes in human peripheral blood lymphocytes. Hypertension (1999) 0.91
Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs. J Hosp Infect (2013) 0.91
Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis. Infect Immun (1993) 0.90
Recognition and treatment of psoriasis. Special considerations in elderly patients. Drugs Aging (1998) 0.90
Cytokines and bullous pemphigoid. Eur Cytokine Netw (1999) 0.90
Vibrio in stinging seaweed: potential infection. Hawaii Med J (1993) 0.89
The association of Helicobacter pylori infection with low levels of urea and pH in the gastric juices. Ital J Gastroenterol (1992) 0.89
Neurotrophins and neurotrophin receptors in human pulmonary arteries. J Vasc Res (2000) 0.89
High prevalence of latent tuberculosis infection in autoimmune disorders such as psoriasis and in chronic respiratory diseases, including lung cancer. J Biol Regul Homeost Agents (2011) 0.88
Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol (1998) 0.88
Neurotrophin and neurotrophin receptor expression in alveolar macrophages: an immunocytochemical study. Growth Factors (2000) 0.87
Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci. Infect Immun (1983) 0.87
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force. Br J Cancer (1995) 0.87
Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasis. Clin Immunol Immunopathol (1997) 0.87
Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia. Clin Reprod Fertil (1986) 0.86
Slight association between type 1 diabetes and "ff" VDR FokI genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications. Clin Biochem (2006) 0.86
Cisplatin-induced hepatic toxicity. J Clin Oncol (1987) 0.86
Epstein-Barr virus-encoded RK-BARF0 protein expression. J Virol (1999) 0.86
Adult acute upper respiratory tract infections in Sicily: pattern of antibiotic drug prescription in primary care. J Antimicrob Chemother (1998) 0.85
Evaluation of guided bone regeneration in rabbit femur using collagen membranes. Implant Dent (2000) 0.85
Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial. Anticancer Res (1996) 0.85
Soluble E-selectin and soluble tumour necrosis factor receptor (60 kD) serum levels in patients with psoriasis. Dermatology (1995) 0.85
c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB. Int J Immunopathol Pharmacol (2006) 0.84
Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease. Eur J Clin Invest (2007) 0.84
Evaluation of a novel tuberculosis complex-specific 34 kDa protein in the serological diagnosis of tuberculosis. Eur Respir J (1995) 0.84
New calculations of the atmospheric cosmic radiation field--results for neutron spectra. Radiat Prot Dosimetry (2004) 0.84
Pulmonary hamartoma. A rare case report. Panminerva Med (1999) 0.84
Spontaneous reporting of adverse drug reactions in elderly patients in Sicily (Italy). Pharmacol Res (1999) 0.84
[Xanthogranulomatous pyelonephritis and renal carcinoma. Report of a clinical case and review of the literature]. Suppl Tumori (2006) 0.84
Increased serum interleukin-15 levels in bullous skin diseases: correlation with disease intensity. Arch Dermatol Res (1999) 0.84
Variations in survival for invasive cervical cancer among European women, 1978-89. EUROCARE Working Group. Cancer Causes Control (1999) 0.84
Very high-dose cisplatin-induced ototoxicity: a preliminary report on early and long-term effects. Cancer Chemother Pharmacol (1988) 0.84
The role of liver transplantation in the treatment of hereditary hemorrhagic telangiectasia: a short literature review. Transplant Proc (2007) 0.84
The clinical impact of different assays for prostate specific antigen. BJU Int (2000) 0.83
The serum levels of sE-selectin are increased in patients with bullous pemphigoid or pemphigus vulgaris. Correlation with the number of skin lesions and recovery after corsticosteroid therapy. Br J Dermatol (1997) 0.83
Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage. Cancer Detect Prev (1985) 0.83
Intron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genes. J Virol (1999) 0.83
Electrospun bioresorbable heart valve scaffold for tissue engineering. Int J Artif Organs (2008) 0.82